NDC 0713-0883 – Evoxac

Cevimeline Hydrochloride 30 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC0713-0883

Product details

Brand name
Evoxac
Generic name
Cevimeline hydrochloride
Labeler
Cosette Pharmaceuticals, Inc.
Dosage form
Capsule
Route
Oral
Marketing category
NDA · NDA020989
Marketed since
September 1, 2022
Listing expires
December 31, 2026
Pharmacologic class
Cholinergic Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Evoxac →

Package NDC codes (1)

Package NDCDescriptionSince
0713-0883-01100 CAPSULE in 1 BOTTLE, PLASTIC (0713-0883-01)Sep 1, 2022